Akebia Therapeutics(us:AKBA)
1.85
+1.09%
Updated on 2024-12-23
Open:1.85
Close:1.85
High:1.87
Low:1.81
Pre Close:1.83
Volume:1.09M
Amount:1.99M
Turnover:0.50%
Shares:218.18M
MarketCap:402.54M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 2 | 1000 | 0.00% | 0 | 0 | 1 |
| 2024-03-31 | 128 | 57038873 | 27.23% | 41 | 27 | 37 |
| 2023-12-31 | 92 | 54756428 | 28.14% | 15 | 23 | 25 |
| 2023-09-30 | 87 | 50859203 | 27.01% | 7 | 20 | 31 |
| 2023-06-30 | 87 | 50244961 | 26.71% | 22 | 10 | 29 |
| 2023-03-31 | 81 | 51980046 | 27.97% | 8 | 15 | 32 |
| 2022-12-31 | 95 | 52267344 | 28.38% | 9 | 7 | 53 |
| 2022-09-30 | 102 | 51747040 | 28.13% | 9 | 17 | 49 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Alerce Investment Management, L.P. | 13205119 | 6.30% | -3000000 | -18.51% |
| 2024-03-31 | Vanguard Group Inc | 8225972 | 3.93% | 618500 | 8.13% |
| 2024-03-31 | Acadian Asset Management Llc | 5309755 | 2.54% | -1605748 | -23.22% |
| 2024-03-31 | Renaissance Technologies Llc | 3652100 | 1.74% | -1127283 | -23.59% |
| 2024-03-31 | Millennium Management Llc | 3266000 | 1.56% | 666013 | 25.62% |
| 2024-03-31 | Blackrock Inc. | 2539225 | 1.21% | -583599 | -18.69% |
| 2024-03-31 | Qube Research & Technologies Ltd | 2262676 | 1.08% | 2005503 | 779.83% |
| 2024-03-31 | Geode Capital Management, Llc | 1818947 | 0.87% | 17257 | 0.96% |
| 2024-03-31 | Susquehanna International Group, Llp | 1762414 | 0.84% | -396950 | -18.38% |
| 2024-03-31 | Jacobs Levy Equity Management, Inc | 1637578 | 0.78% | -219347 | -11.81% |
About
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Address:245 First Street,Suite 1400
Website:http://www.akebia.com
Market Movers